Role of experimental and epidemiological evidence of carcinogenicity in the primary prevention of cancer

Annali dell'Istituto Superiore di Sanita

Volumn 42, Issue 2, 2006, Pages 113-117

  Tomatis, Lorenzo ^a,b  

^a International Society of Doctors for the Environment (ISDE)   (Italy)

^b International Society of Doctors for the Environment (ISDE)   (Italy)

Author keywords

Cancer; Epidemiology; Experimental carcinogenicity; Primary prevention

Indexed keywords

2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; 4 DIMETHYLAMINOAZOBENZENE; BENZIDINE;

CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CAUSAL ATTRIBUTION; DEGENERATIVE DISEASE; EXPERIMENTAL STUDY; GENETICS; HEALTH PROGRAM; HUMAN; MEDICAL SOCIETY; MOLECULAR BIOLOGY; NONHUMAN; OCCUPATIONAL HAZARD; PRIMARY PREVENTION; PUBLIC HEALTH; REVIEW;

ANIMALS; CARCINOGENICITY TESTS; HUMANS; NEOPLASMS; PRIMARY PREVENTION;

EID: 33749822552     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Passey RD. Experimental soot cancer. BMJ 1922;ii:112-3.
2. Tomatis L. Experimental chemical carcinogenesis: its role in the protection of human health in the years 1940's-1970's. Eur J Oncol 2006;11:5-13.
3. Lawley PD. Historical origins of current concepts of carcinogenesis. Adv Cancer Res 1994;65:17-111.
4. Shubik P, Hartwell JL. Survey of compounds which have been tested for carcinogenic activity. Washington, DC: Government Printing Office; 1957. (Public Health Publication, n. 149, Supplement 1).
5. Shubik P, Sice J. Chemical carcinogenesis as a chronic toxicity test: a review. Cancer Res 1956;16:728-42.
6. Kinosita R. Studies on the carcinogenic chemical substances. Trans Jpn Pathol Soc 1937;27:665-727.
7. Wilson RH, DeEds F, Cox AJ. Toxicity and carcinogenic activity of 2-acetylaminofluorene. Cancer Res 1941;1:595-608.
8. Montesano R, Tomatis L. Legislation concerning chemical carcinogens in several industrialized countries. Cancer Res 1977;37:310-6.
9. Camevale F, Montesano R, Partensky C, Tomatis L. Comparisons of regulations on occupational carcinogens in several industrialized countries. Am J Ind Med 1988;12:453-73.
10. Walpole AL, Williams MHC, Roberts DC. The carcinogenic action of 4-aminodiphenyl and 3:2′dimethyl-4-aminodiphenyl. Br J Ind Med 1952;9:255-88.
11. Walpole AL, Williams MHC, Roberts DC. Tumours of the urinary bladder in dogs after ingestion of 4-aminodiphenyl. Br J Ind Med 1954;11:105-9.
12. Melick WF, Escue HM, Naryka JJ, Mezera RA, Wheeler ER. The first reported case of human bladder tumours due to a new carcinogen - xenylamin. J Urol 1955;74:760-4.
13. Rehn L. Bladder tumours in fuchsin workers. Arch Klin Chirurgie 1895;50:588-600.
14. Harris LV, Khava IA. Asbestos: old foe in 21st century developing countries. Sci Total Environ 2003;307:1-9.
15. Ladou J. The asbestos cancer epidemics. Environ Health Perspect 2004;112:265-90.
16. Tomatis L, Huff J. Evolution of research in cancer etiology. In: Coleman WB and Tsongalis GJ (Ed.). The molecular basis of human cancer. Totowa. NJ: Humana Press: 2002. p. 189-201.
17. Bradford Hill A. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
18. Tomatis L, Huff J, Hertz Picciotto I, Sandler DP, Bucher J, Boffetta P, Axelson O, Blair A, Taylor J, Stayner LL, Barrett JC. Avoided and avoidable risks of cancer. Carcinogenesis 1997;18:97-105.
19. Hueper WC, Conway WD. Chemical carcinogenesis and cancers. Sprigfield, Ill: Charles C. Thomas; 1964.
20. World Health Organization. Prevention of Cancer. Geneva, Switzerland: WHO; 1964. (WHO Technical Report Series, n. 176).
21. International Agency for Research on Cancer. Evaluation of carcinogenic risk of chemicals to man. Lyon: IARC; 1970. (IARC Internal Technical Report n. 70/49).
22. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risk of chemicals to man. Vol. 1. Lyon: IARC; 1972.
23. International Agency for Research on Cancer. IARC Monograph Programme on the evaluation of the carcinogenic risk of chemicals to humans. Lyon: IARC; 1977. (IARC Internal Technical Report, n. 77/002).
24. International Agency for Research on Cancer. Chemicals and industrial processes associated with cancer in humans. Lyon: IARC; 1979. (IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Suppl. 1).
25. International Agency for Research on Cancer. Approaches to classifying chemical carcinogens according to mechanism of action. Lyon: IARC; 1983. (IARC Internal Technical Report, n. 83/001).
26. International Agency for Research on Cancer. Mechanisms of carcinogenesis in risk identification. Lyon: IARC; 1991. (IARC Internal Technical Report n. 91/002).
27. Vainio H, Magee PN, McGregor DB, McMichael AJ. Mechanisms of carcinogenicity in risk identification. Lyon: IARC; 1992. (IARC Scientific Publication, n. 116).
28. Tomatis L. The IARC Monographs program: changing attitudes towards public health. Int J Occup Environ Health 2002;8:144-52.
29. Karstadt M. Availability of epidemiologic data for chemicals known to cause cancer in animals. Am J Ind Med 1998;34:519-25.
30. Huff J. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. Int J Occup Environ Health 2002;8:249-10.
31. Knight A, Bailey J, Balcombe J. Which drugs cause cancer? BMJ 2005, 331:E389-91.
32. Farland WH, Rodan B, Preuss P. Which drugs cause cancer? Cancer bioassays. BMJ 2005;331:E389-91.